Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2006 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $6,984,730 | $7,325,930 | $6,426,730 | $8,402,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 23,146,180 | 23,330,440 | 23,430,500 | 23,113,380 |
| Accrued Expenses | N/A | 158,770 | 260,270 | 282,210 | 308,240 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $26,219,870 | $28,130,300 | $27,237,150 | $29,921,680 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 944,590 | 992,170 | 687,040 | 673,670 |
| Other shareholders' equity | 0 | -33,630 | 47,030 | 41,540 | -20,760 |
| TOTAL | $N/A | $1,465,680 | $1,576,610 | $1,607,480 | $1,407,290 |
| Total Liabilities And Equity | $0 | $27,685,550 | $29,706,910 | $28,844,630 | $31,328,970 |